Superficial fungal infections

Published on 08/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 4211 times

Chapter 31 Superficial fungal infections

8. Name the four clinical patterns of tinea capitis.

3. A kerion is an inflammatory fungal infection that may mimic a bacterial folliculitis or an abscess of the scalp (Fig. 31-2C). The scalp is tender to the touch, and the patient usually has posterior cervical lymphadenopathy.

15. What is a dermatophytid reaction?

Dermatophytid reactions are inflammatory reactions at sites distant from the site of the associated dermatophyte infection. Types of dermatophytid reactions from tinea pedis include urticaria, hand dermatitis (Fig. 31-4), or erythema nodosum. The pathogenesis of dermatophytid reactions is not fully understood, but evidence suggests that they are secondary to a strong host immunologic response against fungal antigens.

18. What is tinea versicolor?

Tinea versicolor (pityriasis versicolor) is a hypopigmented, hyperpigmented, or erythematous macular eruption. Macules may coalesce into large patches with an adherent fine scale (Fig. 31-6). Lesions are located predominantly on the trunk but may extend to the extremities. The proper taxonomic nomenclature of the lipophilic yeast that produces this infection is debatable. Studies indicate Malassezia globosa is the organism most frequently associated with tinea versicolor, although most older references list M. furfur as the most common organism. This eruption begins during adolescence, when the sebaceous glands become active. The eruption tends to flare when the temperatures and humidity are high. Immunosuppression, systemic corticosteroids, and sweaty or greasy skin will also cause this disease to flare.

image

Figure 31-4. Dermatophytid reaction.

(Courtesy of Mark Welch, MD.)

image

Figure 31-5. Distal subungual onychomycosis demonstrating a spikelike pattern of infection.

(Courtesy of the Fitzsimons Army Medical Center teaching files.)

Erchiga VC, Florencio VD: Malassezia species in skin diseases, Curr Opin Infect Dis 15:133–142, 2002.

Gupta KA, Batra R, Bluhm R, Faergemann J: Pityriasis versicolor, Dermatol Clin 21: 413–429, 2003.

Prohic A, Ozegovic L: Malassezia species isolated from lesional and non-lesional skin in patients with pityriasis versicolor, Mycoses 50:58–63, 2007.

27. What factors predispose to candidiasis?

The factors that predispose to the development of candidiasis are both endogenous and exogenous. Exogenous factors include occlusion, moisture, and warm temperature. Endogenous factors can include immunosuppression, diabetes mellitus, other endocrinopathies, antibiotics, oral contraceptives, Down syndrome, malnutrition, and pregnancy.

Table 31-2. Clinical Presentations of Cutaneous Candidiasis

DISEASE CLINICAL DESCRIPTION
Intertrigo Superficial pustules, erythema, edema, creamy exudates within skin folds
Thrush White, adherent, cottage cheeselike plaques on oral mucosa
Perlèche Erythema, fissuring, creamy exudate at the angles of the mouth
Paronychia Tender, erythematous, indurated proximal nail fold, with or without a purulent discharge
Erosio interdigitalis blastomycetica Erythema, fissuring, maceration of the webspaces between the fingers

Wagner D, Sohnle P: Cutaneous defenses against dermatophyte and yeasts, Clin Microbiol Rev 8:317–335, 1995.

29. Name the different classes of oral antifungal agents and their mechanisms of action.

See Table 31-3.

Table 31-3. Oral Antifungal Agents

CLASS EXAMPLES MECHANISMS OF ACTION
Antibiotic Griseofulvin Arrest of cellular division, dysfunction of spindle microtubules
Polyenes Nyastatin Binds irreversibly with ergosterol, altering membrane permeability
Azoles Fluconazole
Itraconazole
Ketoconazole
Inhibits ergosterol production by inhibiting the cytochrome P-450 lanosterol 14-demethylase
Allyamines Terbinafine Blocks ergosterol production by inhibiting squalene epoxidase

Data from Gupta A, Sauder D, Shear N: Antifungal agents: part II, J Am Acad Dermatol 30:911–933, 1993.

Gupta A, Sauder D, Shear N: Antifungal agents: part II, J Am Acad Dermatol 30:911–933, 1993.